| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| Pepinemab | VX-15; VX-15/2503; moAb VX-15/2503 | Phase 2 Clinical | Vaccinex Inc | Alzheimer Disease; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Colorectal Neoplasms; Huntington Disease; Melanoma; Multiple Sclerosis; Osteosarcoma; Pancreatic Neoplasms; Skin Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck | Details |